Article metrics

Download PDFPDF

715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023188016
Dec 20233005
Jan 20246706
Feb 20242601
Mar 20244603
Apr 20244203
May 20243003
Jun 20244004
Jul 20246603
Aug 20244004
Sep 20245004
Oct 202440010
Nov 20244804
Dec 202452015
Jan 20254106
Feb 20251407
Mar 2025001
Apr 2025005
May 2025003
Jun 2025005
Total8200108